bladder cancer - search results
If you're not happy with the results, please do another search
Urine Gene Panel Test Predicts Bladder Cancer Years Before Diagnosis
A urine-based test that detects mutations in 60 genes was shown to predict bladder cancer up to 12 years before diagnosis.
Immune Cell that Helps Kill Bladder Cancer Tumors IDed by Mount Sinai Team
Researchers report that they had found a subset of CD8 T cells in bladder cancer that adapt to tumor evasion strategies by appropriating innate-like properties traditionally ascribed to natural killer cells.
Gene Signature Linked with Immunotherapy Response in Bladder Cancer
Investigators at the Cedars-Sinai Cancer Center have identified genetic signatures that may help predict whether tumors in patients with bladder and other cancers will respond to immunotherapy.
Immunotherapy Reduces Bladder Cancer Recurrence
Results from the CheckMate 274 trial show that adjuvant immunotherapy with nivolumab after surgery and chemotherapy helped reduce bladder cancer recurrence in patients with urothelial cancer of the bladder.
Chemo/Immunotherapy Response in Bladder Cancer Improved by Removing the Brake
Adding the anti-inflammatory medication celecoxib to immunotherapy and standard chemotherapy drugs appears to suppress aggressive bladder tumor growth, according to a proof-of-concept study led by investigators from Cedars-Sinai Medical Center.
Genes Linked to Immunotherapy Resistance in Bladder Cancer Uncovered
A Mount Sinai research team has identified genotypes associated with sensitivity and resistance to cancer immunotherapy in patients with metastatic urothelial cancer of the bladder, as well a specific type of white blood cell that helps promote cancer-related inflammation in some people.
New Anti-PD-L1 Study Findings Support Immunotherapy for Bladder Cancer
This single-arm Phase II study investigating two cycles of atezolizumab achieved the primary efficacy endpoint, showing a pathological complete response rate of 31%.
Urine Better than Blood for Determining Bladder Cancer Genomic Profile
Liquid biopsy using urine is better than testing blood when it comes to accurately reflecting the genomic profile of bladder cancer tumors. That’s according...
Liquid Biopsy Test for Bladder Cancer
MDxHealth has launched its AssureMD for Bladder Cancer test in the U.S. as a laboratory developed test (LDT).
Researchers Develop Single Biomarker Assay to Predict Bladder Cancer Recurrence
Urine biomarker test detects urothelial bladder cancer, predicts likelihood of recurrence earlier and more accurately than current methods